1076 related articles for article (PubMed ID: 26781438)
21. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion.
Faraldo MM; Romagnoli M; Wallon L; Dubus P; Deugnier MA; Fre S
Breast Cancer Res; 2024 Jun; 26(1):91. PubMed ID: 38835038
[TBL] [Abstract][Full Text] [Related]
22. Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.
Dunlap SM; Chiao LJ; Nogueira L; Usary J; Perou CM; Varticovski L; Hursting SD
Cancer Prev Res (Phila); 2012 Jul; 5(7):930-42. PubMed ID: 22588949
[TBL] [Abstract][Full Text] [Related]
23. Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.
Heinlein C; Krepulat F; Löhler J; Speidel D; Deppert W; Tolstonog GV
Int J Cancer; 2008 Apr; 122(8):1701-9. PubMed ID: 18092324
[TBL] [Abstract][Full Text] [Related]
24. Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers.
Fougner C; Bergholtz H; Kuiper R; Norum JH; Sørlie T
Breast Cancer Res; 2019 Jul; 21(1):85. PubMed ID: 31366361
[TBL] [Abstract][Full Text] [Related]
25. A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer.
Hollern DP; Contreras CM; Dance-Barnes S; Silva GO; Pfefferle AD; Xiong J; Darr DB; Usary J; Mott KR; Perou CM
Breast Cancer Res Treat; 2019 Feb; 174(1):143-155. PubMed ID: 30484104
[TBL] [Abstract][Full Text] [Related]
26. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
27. Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
Sizemore GM; Balakrishnan S; Hammer AM; Thies KA; Trimboli AJ; Wallace JA; Sizemore ST; Kladney RD; Woelke SA; Yu L; Fernandez SA; Chakravarti A; Leone G; Ostrowski MC
Oncogene; 2017 Apr; 36(16):2297-2308. PubMed ID: 27797378
[TBL] [Abstract][Full Text] [Related]
28. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers.
Pfefferle AD; Agrawal YN; Koboldt DC; Kanchi KL; Herschkowitz JI; Mardis ER; Rosen JM; Perou CM
Dis Model Mech; 2016 Jul; 9(7):749-57. PubMed ID: 27149990
[TBL] [Abstract][Full Text] [Related]
29. Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells.
Rädler PD; Wehde BL; Triplett AA; Shrestha H; Shepherd JH; Pfefferle AD; Rui H; Cardiff RD; Perou CM; Wagner KU
Nat Commun; 2021 Jun; 12(1):3742. PubMed ID: 34145248
[TBL] [Abstract][Full Text] [Related]
30. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
Wang DY; Gendoo DMA; Ben-David Y; Woodgett JR; Zacksenhaus E
Breast Cancer Res; 2019 Jan; 21(1):18. PubMed ID: 30704524
[TBL] [Abstract][Full Text] [Related]
31. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
Reyes C; Jorda M; Gomez-Fernández C
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826
[TBL] [Abstract][Full Text] [Related]
32. Multipotent luminal mammary cancer stem cells model tumor heterogeneity.
Bao L; Cardiff RD; Steinbach P; Messer KS; Ellies LG
Breast Cancer Res; 2015 Oct; 17(1):137. PubMed ID: 26467658
[TBL] [Abstract][Full Text] [Related]
33. Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development.
Wijnhoven SW; Zwart E; Speksnijder EN; Beems RB; Olive KP; Tuveson DA; Jonkers J; Schaap MM; van den Berg J; Jacks T; van Steeg H; de Vries A
Cancer Res; 2005 Sep; 65(18):8166-73. PubMed ID: 16166291
[TBL] [Abstract][Full Text] [Related]
34. p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
[TBL] [Abstract][Full Text] [Related]
35. Crucial and novel cancer drivers in a mouse model of triple-negative breast cancer.
Johnson JP; Kumar P; Koulnis M; Patel M; Simin K
Cancer Genomics Proteomics; 2014; 11(3):115-26. PubMed ID: 24969692
[TBL] [Abstract][Full Text] [Related]
36. Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors.
Wang Q; Ding H; Wang H; Li P; Liu B; Zhang K
Oncol Rep; 2015 Jan; 33(1):179-84. PubMed ID: 25354531
[TBL] [Abstract][Full Text] [Related]
37. PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.
Boelens MC; Nethe M; Klarenbeek S; de Ruiter JR; Schut E; Bonzanni N; Zeeman AL; Wientjens E; van der Burg E; Wessels L; van Amerongen R; Jonkers J
Cell Rep; 2016 Aug; 16(8):2087-2101. PubMed ID: 27524621
[TBL] [Abstract][Full Text] [Related]
38. Combined p53- and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer.
Gasparyan M; Lo MC; Jiang H; Lin CC; Sun D
J Biol Chem; 2020 Aug; 295(34):12188-12202. PubMed ID: 32467227
[TBL] [Abstract][Full Text] [Related]
39. Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.
Treekitkarnmongkol W; Katayama H; Kai K; Sasai K; Jones JC; Wang J; Shen L; Sahin AA; Gagea M; Ueno NT; Creighton CJ; Sen S
Carcinogenesis; 2016 Dec; 37(12):1180-1189. PubMed ID: 27624071
[TBL] [Abstract][Full Text] [Related]
40. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
